Dana-Farber Cancer Institute

Oncology

Richard Stone, MD is currently the Director of the Adult Acute Leukemia Program at DFCI, serves on the Medical Oncology Board of the American Board of Internal Medicine, and is vice chair of the Leukemia Core Committee for the national cooperative trials group Cancer and Leukemia Group B. He also serves as a Professor of Medicine at Harvard Medical School. His clinical interests are Leukemias, Myelodysplastic syndromes and Myeloproliferative disorders.